Skip to content

Study on the effect of Sihuang Zijin Powder Colloid in the treatment of infusion phlebitis in tumor patients: A randomized controlled study

Study on the effect of Sihuang Zijin Powder Colloid in the treatment of infusion phlebitis in tumor patients: A randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088521
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-08-20
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infusion phlebitis in tumor patients

Interventions

Control group::After phlebitis occurs, 50% magnesium sulfate is poured on gauze to cover the affected area and wrapped with plastic wrap to keep moist. The area exceeds the upper and lower parts of th
Standard control group:After the occurrence of phlebitis, the hydrocolloid was affixed to the affected area, the area was 2 cm above and below the affected area, the left and right sides of the phlebi
Experimental group:After the occurrence of phlebitis, stick Sihuang Zijin powder colloid on the affected area, the area beyond the affected area, left and right 2cm once a day, each retention time is

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) the occurrence of IP during and after infusion meets the diagnostic criteria of traditional Chinese and western medicine. (2) patients who received parenteral nutrition via peripheral vein infusion (3) patients whose puncture site is the vein of the back of hand and forearm and the age is = 18 years old. (4) the infusion speed is 40-70 drops / min. (5) clear consciousness and stable vital signs. (6) patients without vascular underlying diseases and coagulation system diseases. (7) those who voluntarily participate in this study, agree to use topical drugs and sign informed consent forms.

Exclusion criteria

Exclusion criteria: (1) patients with a history of original vein injury or repeated puncture has caused vein injury (2) patients also receive other irritant or corrosive drugs in addition to parenteral nutrition. (3) those who are allergic to experimental drugs (4) there are diseases such as upper limb edema, skin injury, inflammation or rash at the venipuncture.

Design outcomes

Primary

MeasureTime frame
Phlebitis grading;Pain score;

Secondary

MeasureTime frame
Patient satisfaction;

Countries

CHINA

Contacts

Public ContactHOU JIANWEN

Zhejiang Cancer Hospital

945298500@qq.com+86 13 567 114 7265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026